{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T02:20:00Z","timestamp":1785032400725,"version":"3.55.0"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,7]]},"abstract":"<jats:sec>\n            <jats:title>Objective:<\/jats:title>\n            <jats:p>The primary endpoint was to analyze the predictive factors of lymph node involvement (LN+).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Indications for additional right hemicolectomy (RHC) with lymph node (LN) resection after appendectomy for appendix neuroendocrine tumor (A-NET) remain controversial, especially for tumors between 1 and 2\u200acm in size.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>National study including all patients with nonmetastatic A-NET diagnosed after January, 2010 in France.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>In all, 403 patients were included. A-NETs were: within tip (67%), body (24%) or base (9%) of the appendix; tumor size was &lt;\u200a1\u200acm (62%), 1 to 2\u200acm (30%), or &gt;2\u200acm (8%); grade 1 (91%); mesoappendix involvement 3\u200amm (5%); lymphovascular (15%) or perineural (24%) invasion; and positive resection margin (8%). According to the European NeuroEndocrine Tumor Society (ENETS) recommendations, 85 patients (21%) should have undergone RHC. The agreement between ENETS guidelines and the multidisciplinary tumor board for complementary RHC was 89%. In all, 100 (25%) patients underwent RHC with LN resection, 26 of whom had LN+. Tumor size (best cut-off at 1.95\u200acm), lymphovascular and perineural invasion, and pT classifications were associated with LN+. Among the 44 patients who underwent RHC for a tumor of 1 to 2\u200acm in size, 8 (18%) had LN+. No predictive factor of LN+ (base, resection margins, grade, mesoappendix, lymphovascular, perineural involvement) was found in this subgroup of patients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>In the largest study using the latest pathological criteria for completion RHC in A-NET, a quarter of patients had residual tumor. Further studies are warranted to demonstrate the survival impact of RHC in this setting.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/sla.0000000000002736","type":"journal-article","created":{"date-parts":[[2018,3,20]],"date-time":"2018-03-20T17:59:42Z","timestamp":1521568782000},"page":"165-171","source":"Crossref","is-referenced-by-count":81,"title":["Current Management and Predictive Factors of Lymph Node Metastasis of Appendix Neuroendocrine Tumors"],"prefix":"10.1097","volume":"270","author":[{"given":"B\u00e9r\u00e9nice","family":"Rault-Petit","sequence":"first","affiliation":[{"name":"Hospices Civils de Lyon, H\u00f4pital Edouard Herriot, Service de Gastroent\u00e9rologie et d\u2019Oncologie M\u00e9dicale, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Do Cao","sequence":"additional","affiliation":[{"name":"Service d\u2019endocrinologie, H\u00f4pital Claude Huriez, CHRU Lille, Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serge","family":"Guy\u00e9tant","sequence":"additional","affiliation":[{"name":"Service d\u2019anatomie et cytologie pathologiques, CHRU Tours, Tours, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosine","family":"Guimbaud","sequence":"additional","affiliation":[{"name":"Service d\u2019oncologie digestive, CHU Toulouse, Toulouse, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Rohmer","sequence":"additional","affiliation":[{"name":"Service d\u2019endocrinologie, diab\u00e9tologie et nutrition, CHU Angers, Angers, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Juli\u00e9","sequence":"additional","affiliation":[{"name":"Service d\u2019anatomie et cytologie pathologiques, CHU Ambroise Par\u00e9, Boulogne Billancourt, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Baudin","sequence":"additional","affiliation":[{"name":"Service d\u2019endocrinologie, oncologie m\u00e9dicale, Institut Gustave Roussy, Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Goichot","sequence":"additional","affiliation":[{"name":"Service de M\u00e9decine Interne, Endocrinologie et Nutrition, CHU H\u00f4pital de Hautepierre, Strasbourg, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romain","family":"Coriat","sequence":"additional","affiliation":[{"name":"Service de gastro-ent\u00e9rologie, oncologie digestive, H\u00f4pital Cochin, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Tabarin","sequence":"additional","affiliation":[{"name":"Service de l\u2019appareil digestif, endocrinologie et nutrition, CHU Bordeaux, Bordeaux, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanne","family":"Ramos","sequence":"additional","affiliation":[{"name":"Service d\u2019anatomie et cytologie pathologiques, CHU-H\u00f4pital Gui de Chauliac, Montpellier, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Goudet","sequence":"additional","affiliation":[{"name":"Service de chirurgie, CHU Dijon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Hervieu","sequence":"additional","affiliation":[{"name":"Hospices Civils de Lyon, H\u00f4pital Edouard Herriot, Service Central d\u2019Anatomie et Cytologie Pathologiques, Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Yves","family":"Scoazec","sequence":"additional","affiliation":[{"name":"Service d\u2019anatomie et cytologie pathologiques, Institut Gustave Roussy, Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Walter","sequence":"additional","affiliation":[{"name":"Hospices Civils de Lyon, H\u00f4pital Edouard Herriot, Service de Gastroent\u00e9rologie et d\u2019Oncologie M\u00e9dicale, Lyon, France"},{"name":"University of Lyon, Universit\u00e9 Lyon 1, France."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20231021","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/S1479-666X(08)80049-2","article-title":"Are we missing diagnostic opportunities in cases of carcinoid tumours of the appendix?","volume":"6","author":"Debnath","year":"2008","journal-title":"Surgeon"},{"key":"R2-20231021","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1677\/ERC-10-0152","article-title":"Gastroenteropancreatic neuroendocrine tumours: the current incidence and staging based on the WHO and European Neuroendocrine Tumour Society classification: an analysis based on prospectively collected parameters","volume":"17","author":"Niederle","year":"2010","journal-title":"Endocr Relat Cancer"},{"key":"R3-20231021","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/1097-0142(196802)21:2<270::AID-CNCR2820210217>3.0.CO;2-9","article-title":"Carcinoid tumors of the vermiform appendix","volume":"21","author":"Moertel","year":"1968","journal-title":"Cancer"},{"key":"R4-20231021","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1007\/s11605-008-0545-4","article-title":"Carcinoid tumour of the appendix: an analysis of 1,485 consecutive emergency appendectomies","volume":"12","author":"In\u2019t Hof","year":"2008","journal-title":"J Gastrointest Surg"},{"key":"R5-20231021","doi-asserted-by":"crossref","first-page":"3307","DOI":"10.1002\/cncr.10589","article-title":"Primary malignant neoplasms of the appendix: a population-based study from the surveillance, epidemiology and end-results program, 1973\u20131998","volume":"94","author":"McCusker","year":"2002","journal-title":"Cancer"},{"key":"R6-20231021","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1200\/JCO.2007.15.4377","article-title":"One hundred years after \u201ccarcinoid\u201d: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States","volume":"26","author":"Yao","year":"2008","journal-title":"J Clin Oncol"},{"key":"R7-20231021","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/01.sla.0000129342.67174.67","article-title":"Updated population-based review of carcinoid tumors","volume":"240","author":"Maggard","year":"2004","journal-title":"Ann Surg"},{"key":"R8-20231021","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s00428-010-0924-6","article-title":"The ENETS and AJCC\/UICC TNM classifications of the neuroendocrine tumors of the gastrointestinal tract and the pancreas: a statement","volume":"456","author":"Kl\u00f6ppel","year":"2010","journal-title":"Virchows Arch"},{"key":"R10-20231021","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1097\/MPA.0b013e3181ebb2a5","article-title":"The NANETS consensus guideline for the diagnosis and management of neuroendocrine tumors: well-differentiated neuroendocrine tumors of the jejunum, ileum, appendix, and cecum","volume":"39","author":"Boudreaux","year":"2010","journal-title":"Pancreas"},{"key":"R11-20231021","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1159\/000443165","article-title":"ENETS consensus guidelines for neuroendocrine neoplasms of the appendix (excluding goblet cell carcinomas)","volume":"103","author":"Pape","year":"2016","journal-title":"Neuroendocrinology"},{"key":"R13-20231021","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1136\/gutjnl-2011-300831","article-title":"Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs)","volume":"61","author":"Ramage","year":"2012","journal-title":"Gut"},{"key":"R14-20231021","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/j.1572-0241.1998.00422.x","article-title":"A retrospective analysis of 1570 appendiceal carcinoids","volume":"93","author":"Sandor","year":"1998","journal-title":"Am J Gastroenterol"},{"key":"R15-20231021","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1056\/NEJM198712313172704","article-title":"Carcinoid tumor of the appendix: treatment and prognosis","volume":"317","author":"Moertel","year":"1987","journal-title":"N Engl J Med"},{"key":"R16-20231021","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/jso.21888","article-title":"Carcinoid tumors of the appendix: a population-based study","volume":"104","author":"Mullen","year":"2011","journal-title":"J Surg Oncol"},{"key":"R17-20231021","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/00000658-197907000-00013","article-title":"Carcinoid tumors of the appendix. Mesoappendiceal extension and nodal metastases","volume":"190","author":"Syracuse","year":"1979","journal-title":"Ann Surg"},{"key":"R18-20231021","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1309\/199VD990LVHPTQUM","article-title":"Does mesoappendix infiltration predict a worse prognosis in incidental neuroendocrine tumors of the appendix? A clinicopathologic and immunohistochemical study of 15 cases","volume":"120","author":"Rossi","year":"2003","journal-title":"Am J Clin Pathol"},{"key":"R19-20231021","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1097\/PAS.0b013e318275d1d7","article-title":"Tumor staging but not grading is associated with adverse clinical outcome in neuroendocrine tumors of the appendix: a retrospective clinical pathologic analysis of 138 cases","volume":"37","author":"Volante","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"R20-20231021","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1001\/archsurg.141.4.349","article-title":"Is right hemicolectomy for 2.0-cm appendiceal carcinoids justified?","volume":"141","author":"Bamboat","year":"19602006","journal-title":"Arch Surg Chic Ill"},{"key":"R21-20231021","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/pbc.25823","article-title":"Surgical management of neuroendocrine tumors of the appendix in children and adolescents: a retrospective french multicenter study of 114 cases","volume":"63","author":"De Lambert","year":"2016","journal-title":"Pediatr Blood Cancer"},{"key":"R22-20231021","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1177\/030089160709300612","article-title":"Appendectomy or right hemicolectomy in the treatment of appendiceal carcinoid tumors?","volume":"93","author":"Fornaro","year":"2007","journal-title":"Tumori"},{"key":"R23-20231021","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/BF03347081","article-title":"Clinical value of right hemicolectomy for appendiceal carcinoids using pathologic criteria","volume":"34","author":"Alexandraki","year":"2011","journal-title":"J Endocrinol Invest"},{"key":"R24-20231021","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.ejso.2015.06.010","article-title":"Management and outcomes of appendicular neuroendocrine tumours: Retrospective review with 5-year follow-up","volume":"41","author":"Amr","year":"2015","journal-title":"Eur J Surg Oncol"},{"key":"R25-20231021","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s00428-007-0452-1","article-title":"TNM staging of midgut and hindgut (neuro) endocrine tumors: a consensus proposal including a grading system","volume":"451","author":"Rindi","year":"2007","journal-title":"Virchows Arch"},{"key":"R26-20231021","doi-asserted-by":"crossref","first-page":"R27","DOI":"10.1530\/ERC-15-0310","article-title":"Appendiceal neuroendocrine neoplasms: diagnosis and management","volume":"23","author":"Alexandraki","year":"2016","journal-title":"Endocr Relat Cancer"},{"key":"R27-20231021","first-page":"543","article-title":"Indications for right hemicolectomy in carcinoid tumors of the appendix. The French Associations for Surgical Research","volume":"176","author":"Gouzi","year":"1993","journal-title":"Surg Gynecol Obstet"},{"key":"R28-20231021","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000343801","article-title":"Current size criteria for the management of neuroendocrine tumors of the appendix: are they valid? Clinical experience and review of the literature","volume":"98","author":"Grozinsky-Glasberg","year":"2013","journal-title":"Neuroendocrinology"},{"key":"R29-20231021","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1001\/jamaoncol.2017.0589","article-title":"Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States","volume":"3","author":"Dasari","year":"2017","journal-title":"JAMA Oncol"},{"key":"R30-20231021","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1001\/archsurg.143.7.664","article-title":"Analysis of 900 appendiceal carcinoid tumors for a proposed predictive staging system","volume":"143","author":"Landry","year":"19602008","journal-title":"Arch Surg Chic Ill"},{"key":"R31-20231021","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.jamcollsurg.2015.01.005","article-title":"Management of 1- to 2-cm carcinoid tumors of the appendix: using the National Cancer Data Base to address controversies in general surgery","volume":"220","author":"Nussbaum","year":"2015","journal-title":"J Am Coll Surg"},{"key":"R32-20231021","first-page":"123","article-title":"Carcinoid tumors of the appendix. Prognostic factors and evaluation of indications for right hemicolectomy","volume":"52","author":"Safioleas","year":"2005","journal-title":"Hepatogastroenterology"},{"key":"R33-20231021","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1002\/bjs.1800720715","article-title":"Carcinoid tumours of the appendix","volume":"72","author":"Anderson","year":"1985","journal-title":"Br J Surg"},{"key":"R34-20231021","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/ped.12047","article-title":"Appendix carcinoids in childhood: long-term experience at a single institution in Western Canada and systematic review","volume":"55","author":"Kulkarni","year":"2013","journal-title":"Pediatr Int"},{"key":"R35-20231021","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1007\/s00268-002-6440-3","article-title":"Retrospective evaluation of carcinoid tumors of the appendix in children","volume":"26","author":"Prommegger","year":"2002","journal-title":"World J Surg"},{"key":"R36-20231021","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/codi.13082","article-title":"Laparoscopic and open right-sided colonic resection in daily routine practice. A prospective multicentre study within an Enhanced Recovery After Surgery (ERAS) protocol","volume":"18","author":"Tiefenthal","year":"2016","journal-title":"Colorectal Dis"},{"key":"R37-20231021","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s003830000559","article-title":"Carcinoid tumors of the appendix in children","volume":"17","author":"Pelizzo","year":"2001","journal-title":"Pediatr Surg Int"},{"key":"R38-20231021","first-page":"3999","article-title":"Secretoneurin in carcinoids of the appendix-immunohistochemical comparison with chromogranins A, B and secretogranin II","volume":"18","author":"Prommegger","year":"1998","journal-title":"Anticancer Res"},{"key":"R39-20231021","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1053\/j.semdp.2004.11.004","article-title":"Neuroendocrine tumors of the appendix","volume":"21","author":"Carr","year":"2004","journal-title":"Semin Diagn Pathol"}],"container-title":["Annals of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00000658-201907000-00026","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,21]],"date-time":"2023-10-21T03:09:03Z","timestamp":1697857743000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00000658-201907000-00026"}},"subtitle":["A National Study from the French Group of Endocrine Tumors (GTE)"],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/sla.0000000000002736","relation":{},"ISSN":["0003-4932","1528-1140"],"issn-type":[{"value":"0003-4932","type":"print"},{"value":"1528-1140","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7]]}}}